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In Amazonas  State  (Brazil),  Justicia  acuminatissima  (Miq.)  Bremek.,  Acanthaceae,  leaf  teas  are  used  in
folk  medicine  to treat several  inﬂammatory  illnesses.  In order  to  validate  this  medicinal  application,
we  analyzed  the acute  toxicity  and  antioxidant,  antiedematogenic  and  antinociceptive  potentials  of  an
aqueous  extract  of  this  species,  using  culture  cells  and  animal  models.  The  aqueous  extract  did  not  cause
toxic effects  on  human  lymphocytes  in  high  concentration  (400 g/ml),  neither  on  mice treated  with  high
doses  (5000  mg/kg)  in  an  acute  toxicity  analysis  by oral  route,  and also  did  not  cause  lesions  in the  gastric
mucosa  of  animals  treated  with  300  mg/kg,  which  was  the  maximal  dose  used  in the  anti-inﬂammatory
screening.  The  aqueous  extract  caused  inhibition  of  inﬂammatory  pain  in  formalin-induced  paw  licking
test  with  all  tested  doses,  30, 100  and  300  mg/kg,  and  antiedematogenic  activity  at  100  and  300  mg/kg.OX-2
Additionally,  the aqueous  extract  presented  statistically  signiﬁcant  action  on  the release  of  nitric  oxide  by
lipopolysaccharide-activated  macrophages.  These  results  and  other  preliminary  studies  support  the  folk
use of  this  species,  and  further  investigation  of  its action  mechanism  by  inhibition  of COX-2  or  related
metabolite  would  be  interesting.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Inﬂammation plays a crucial role in the pathogenic mecha-
isms of various diseases, since it is triggered by various stimuli
f physical, chemical and biological origin (Ganesh, 2014). Two
f the most prominent molecular mechanisms implied in the
nﬂammatory response, among many others, are the production of
itric oxide (NO) by inducible NO synthase (iNOS) and the release
f prostaglandins by cyclooxygenases (COX). While the use of
NOS inhibitors as anti-inﬂammatory medicines still requires more
tudies (Rochette et al., 2013), non-steroidal anti-inﬂammatory
rugs (NSAIDs) are an important group of drugs largely utilized
n treatment of inﬂammatory diseases, acting by inhibition of COX
nzymes (Blackler et al., 2014). However, the use of these medicines
s frequently related with disorders on gastric mucosa, as well as
he renal and cardiovascular systems (Harirforoosh et al., 2013).Plant extracts are valuable leads for multi-target drugs due the
nterplay of their multiple components. It becomes more evident
hat, for complex diseases like inﬂammation, an interference with
∗ Corresponding author.
E-mail: guilhon simplicio@ufam.edu.br (F. Guilhon-Simplicio).
http://dx.doi.org/10.1016/j.bjp.2015.05.002
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoramultiple targets is superior to targeting a single key factor regarding
drug efﬁciency, side effects and adverse compensatory mechanisms
(Koeberle and Werz, 2014). Indeed, various research groups have
studied different plants used in traditional medicine for the dis-
covery of new anti-inﬂammatory drugs, which are more safe and
efﬁcient.
In traditional medicine around the world, the largest genus of
Acanthaceae family, Justicia,  is used for treating various health
complications, including toothache, heart diseases, gastrointesti-
nal disturbances and even AIDS. In Brazil, different species are
used for treating pain, fever, respiratory problems and headaches,
and many pharmacological properties were scientiﬁcally proven,
including anti-inﬂammatory activity (Côrrea and Alcântara, 2012).
On the other hand, leaf tea of Justicia acuminatissima (Miq.) Bre-
mek., a native subshrub of the Brazilian Amazon rainforest, known
as “sara-tudo”, is usually used in folk medicine to treat inﬂamma-
tory illness in the Amazonas State, although its pharmacological
potential was not known until recently.
A study investigated phytochemically and pharmacologically a
few organic extracts and substances obtained from this species
(Côrrea, 2013). However, the anti-inﬂammatory potential and the
possible toxic effects of an aqueous extract after oral consump-
tion, mimicking traditional use, remained unknown. Therefore,
 Ltda. All rights reserved.
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his study aims to investigate the anti-inﬂammatory potential of J.
cuminatissima aqueous extract by oral route in order to validate its
opular use. We  analyzed cytotoxic effects on human lymphocytes,
cute toxicity on experimental animals and a possible ulcerogenic
ffect after oral administration to evaluate the safe of its use. We
nalyzed its inhibition capacity of the release of NO by human
acrophages stimulated by lipopolysaccharides, and also the anal-
esic and antiedematogenic activities in experimental animals in
rder to formulate the preliminary considerations about its alleged
nti-inﬂammatory potential.
aterials and methods
lant material
The collection of samples was authorized by the Managing
ouncil of the Genetic Patrimony (CGEN), chaired by the Ministry
f Environment (Brazil), under the registration 034/2008. Leaves of
usticia acuminatissima (Miq.) Bremek., Acanthaceae, were collected
t Careiro Castanho, 100 km south of Manaus, capital of Amazonas
tate, Brazil. A voucher specimen (224414) was  deposited at the
erbarium of Instituto Nacional de Pesquisas da Amazônia, after
dentiﬁcation and taxonomic authentication by José Lima.
reparation of the extract
The leaves were dried at 40 ◦C in a stove for 72 h (WHO, 2003),
nd then scraped and pulverized using a mechanical grinder. The
owder was macerated with distilled water under agitation for 72 h
10% aqueous extract). The extract, named PMFA in this work, was
hen vacuum-ﬁltered, lyophilized and conserved 2–8 ◦C for further
se.
ell culture
Human lymphocytes were isolated using a gradient of Ficoll –
istopaque (1 blood: 1 ﬁcoll) from peripheral venous blood (5 ml)
ollected in heparinized vials from one normal, healthy donor, with
o history of smoking/drinking or chronic use of medication. J774
urine macrophage cells were obtained from Rio de Janeiro Cell
ank, Rio de Janeiro, Brazil, and cultured at 37 ◦C in a humidiﬁed
ncubator with 5% CO2 in RPMI-1640 medium containing 10% fetal
ovine serum (FBS), 50 U/ml penicillin and 50 g/ml streptomycin
Sigma).
nimals
Male and female Swiss mice (30 ± 5 g) and Wistar rats
160–220 g) were maintained in a temperature-controlled room
23 ± 2 ◦C) with a 12/12 h light–dark cycle and acclimatized in
he experimental environment for at least 24 h before the tests.
ater and a balanced diet were continually provided ad libitum,
ut food was withdrawn 12 h before the tests. The tests were per-
ormed in accordance with the Conselho Nacional de Controle da
xperimentac¸ ão Animal and were authorized by the Ethical Com-
ittee on the Use of Animals of Universidade Federal do Amazonas,
nder registration 002/2015.
ytotoxicity on human lymphocytes
Peripheral blood lymphocytes (PBL) were seeded in 96-well
lates (105 cells per well), and were treated with PMFA, and
he Alamar BlueTM assay was performed on them (Ahmed et al.,
994). PMFA (400–6.25 g/ml) was dissolved in dimethyl sulf-
xide (DMSO), added to each well, and was incubated for 72 h.
oxorubicin was used as positive control. Control groups receivedFarmacognosia 25 (2015) 264–268 265
the same amount of DMSO (0.1%). Four hours before the end of
the incubations, 10 l of Alamar BlueTM was  added to each well.
The ﬂuorescent signal was monitored using a multiplate reader
using 530–560 nm excitation wavelength and 590 nm emission
wavelength. The ﬂuorescent signal generated from the assay was
proportional to the number of living cells in the sample.
Acute toxicity
Six mice (three male and three female) received orally the
maximal dose of 5000 mg/kg of PMFA dissolved in fresh water.
Two animals (1 male and 1 female) were used as negative con-
trol and received 10 ml/kg of fresh water. Abnormal morphological
and behavior signs of toxic/pharmacological effects (Hippocratic
screening) were observed during the ﬁrst 4 h after administration
of extract and at every 24 h for 14 days (Malone and Robichaud,
1962).
Ulcerogenic effect
Three different groups of six rats (three male and three female)
received orally 300 mg/kg of PMFA, 10 mg/kg of indomethacin (pos-
itive control) and 10 ml/kg of fresh water (vehicle, negative control).
The animals were then anesthetized and sacriﬁced by cervical dis-
location. Their stomachs were removed and opened along the great
curvature, and their inner surface was  examined in order to look
for gastric lesions (Lapa et al., 2008).
NO production assay
After the pre-incubation of J774 murine macrophages
(1 × 105 cells/ml) with different concentrations of PMFA for
2 h, the cells were washed and incubated for 24 h either with or
without bacterial lipopolysaccharide (LPS, 1 g/ml) at 37 ◦C in
a 5% CO2 incubator. NO was  measured as nitrite (NO2−), in the
culture supernatant by reaction with Griess reagent, followed by
measuring at 532 nm using a microplate reader (DTX 800, Beckman
Coulter®, California, EUA). Sodium nitrite was used as a standard
to calculate nitrite concentrations (Verma et al., 2012).
Formalin-induced paw licking test
Groups of six mice (three male and three female) received 30,
100 and 300 mg/kg of PMFA, 10 mg/kg of indomethacin (positive
control 1), 50 l/kg of fentanyl (positive control 2) and 10 ml/kg
of fresh water (vehicle, negative control), all orally administered.
One hour after, formalin at 2.0% was injected in the right hind paw
of all the animals, and the duration of paw licking was counted in
periods of 0–5 min  (early phase) and 15–30 min  (late phase). The
results were compared with the negative control (Lapa et al., 2008).
Carrageenan-induced paw edema
Doses of 30, 100 and 300 mg/kg of PMFA in fresh water were
administered orally in different groups of six rats (three male
and three female). Two  other groups received indomethacin at
10 mg/kg (positive control) and water (negative control). After 1 h,
0.3 ml  of -carrageenan 2% in normal saline was injected in the
right hind paw of all animals, and the paw edema progression was
measured using a digital plethysmometer, in hourly intervals, for
5 h (Winter et al., 1962).Statistical analysis
The results were expressed as the mean ± standard deviation.
The results were compared by one or two-way analysis of variance
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doses (Fig. 3), without difference between them, which indicates,
in advance, the signiﬁcant anti-inﬂammatory potential of J. acumi-
natisima and reinforces the hypothesis of a possible action of PMFA
on COX-2 or a derivate.
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μg/mlig. 1. Effect of aqueous extract of Justicia acuminatissima on the gastric mucosa of ra
ucosa  after administration of the extract PMFA at 300 mg/kg. (C) Comparison of t
y  one-way analysis of variance (ANOVA)/Dunnett’s test, p-values versus negative c
ANOVA) using GraphPad Prism6® software (San Diego, California,
SA), considering values of p < 0.05 statistically signiﬁcant.
esults and discussion
We  did not observe any cytotoxic effects in human lymphocytes
xposed to maximal dose of 400 g/ml of PMFA during 72 h. In addi-
ion, the animals exposed to very high dose of PMFA (5000 mg/kg
.o.) did not present toxicity signs and no death occurred during
ippocratic screening. These results suggested that the use of J.
cuminatissima leaf tea by oral route is safe, although toxicity after
ong time exposition should be further investigated. Thus, three
paced doses, 30, 100 and 300 mg/kg, were selected for analysis of
heir anti-inﬂammatory potential.
Considering that ulceration is one of the more deleterious
ollateral effects of traditional anti-inﬂammatory medicines, the
lcerogenic potential of PMFA was evaluated after the adminis-
ration of the higher dose tested in the anti-inﬂammatory activity
tudy. In this assay we observed that PMFA at 300 mg/kg did not
nduce stomach ulcer, whereas indomethacin 10 mg/kg induced
 signiﬁcant ulceration, with p < 0.05 (one-way ANOVA/Dunnett’s
est) in comparison to negative control (Fig. 1).
Traditional NSAIDs inhibit both isoforms of COX and their
dverse gastrointestinal toxicities are related to the inhibition of
astroprotective prostaglandins, produced by COX-1 pathway. The
esults of evaluation of gastric lesions after exposition to high dose
f PMFA are in agreement with clinical studies where non-selective
SAI was compared with COX-2 inhibitors and the ulcer index
as observed, suggesting that PMFA might act by a mechanism
ndependent of COX-1 inhibition (Kangwan et al., 2014). Empha-
izing this, in a previous study we demonstrated that PMFA has no
ffect on platelet aggregation in vitro (Verdam et al., 2009), which
s dependent on action of this enzyme (Dovizio et al., 2014).
NO released by activated macrophages has a critical role
n the inﬂammatory response, including activation of the COX
nzymes, resulting in exacerbated production of pro-inﬂammatory
rostaglandins. Furthermore, NO is a potent vasodilator and had
he ability to increase vascular permeability and edema through
hanges in local blood ﬂow (Gamper and Ooi, 2014). PMFA sig-
iﬁcantly inhibit the formation of NO2−, an oxidized form of NO
eleased by LPS-activated macrophages. Since this NO production
lso reﬂects the activity of iNOS (Verma et al., 2012), this effect can
e due to radical scavenging activity or inhibitory effect on enzyme
Fig. 2). Gastric mucosa damage after indomethacin administration at 10 mg/kg. (B) Gastric
hest concentration of PMFA analyzed and positive and negative controls analyzed
l: *p < 0.05.
In biological medium, the oxidation of NO to cytotoxic radical
anion peroxynitrite (ONOO−), by combination with anion super-
oxide radical (O2•−), is an important event in the aggravation of
inﬂammatory processes, including those induced by carrageenan
(Salvemini et al., 1996a), since it has already been demonstrated
that inhibition of excessive production of NO reduces edema
(Salvemini et al., 1996b). On the other hand, evidences showed that
NO and ONOO− facilitate PGE2-induced hyperalgesia, but has lower
hyperalgesic action when acting alone (Ndengele et al., 2008).
The injection of dilute formalin produces a persistent biphasic
nociceptive stimulation noted by the behavioral pain responses
of licking, ﬂexing and jerking of the injected paw (Lariviere
et al., 2011). The early phase of response (within 0–5 min  after
injection) comprises the neurogenic pain, while the late phase
(within 15–60 min  after injection) comprises the inﬂammatory
pain (hyperalgesia) (Lapa et al., 2008). In our study, PMFA did not
inhibit the early phase of the pain, indicating that the extract is
not effective to control neurogenic pain. However, PMFA presented
anti-hyperalgesic activity statistically signiﬁcant with all testedFig. 2. Effect of different concentrations of PMFA extracts on nitrite production
by  murine macrophages J774 stimulated with lipopolysaccharide (LPS 1 g/ml) for
24 h. Comparison of the concentrations analyzed by the Holm–Sidak test, p-values
versus positive control: *p < 0.05, **p < 0.01, ***p < 0.001, and p-value versus negative
control: p < 0.05, p < 0.01, p < 0.001.
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Tig. 3. Effect of aqueous extract of Justicia acuminatissima p.o. (30, 100 and 300 mg/
he  formalin test. Two-way ANOVA/Bonferroni, p-values versus negative control: *p
Edema is another important sign of inﬂammation. In the
arrageenan-induced paw edema model, rats paw volume is
ecorded at different time points using a plethysmometer, and this
arameter may  be used for inference on anti-inﬂammatory activity
f various samples (Winter et al., 1962). Two phases of inﬂam-
atory response caused by carrageenan are well established. The
rst phase occurs one hour after polysaccharide injection, and is
ainly related to the release of histamine, serotonin, bradykinin,
latelet activating factor and leukotrienes. The second phase occur-
ing within the ﬁrst and third hours (peak of the inﬂammatory
esponse) is due to the products release from COX-1 and COX-2
etabolism (Vinegar et al., 1969). PGs such as PGE2 and PGI2 pro-
uced via the COX-2 pathway magnify the degree of inﬂammation
nitiated by other mediators of inﬂammation such as histamine and
radykinin leading to increased vascular permeability and edema
Kawahara et al., 2014).
PMFA presented statistically signiﬁcant antiedematogenic
ctivity in both phases after carrageenan injection (Fig. 4), pre-
enting no difference in relation to positive control (indomethacin
t 10 mg/kg weight). This result, however, reafﬁrms the anti-
nﬂammatory potential of the studied species. Comparing the
esults of the evaluation of the anti-hyperalgesic and antiedemato-
enic activities of PMFA, it can be inferred that the popular reports
f healing of inﬂammatory processes by users of the J. acuminatis-
ima leaf teas are more directly related to pain relief, which is the
ost troublesome symptom of inﬂammation, since all tested doses
ere active.
We  previously showed that condensed tannins, coumarins and
aponins form the majority of the secondary metabolites in J.
cuminatissima leaves (Verdam et al., 2009). The saponins inhibit
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ig. 4. Effect of aqueous extract of Justicia acuminatissima p.o. (30, 100 and
00  mg/kg) in the early and late phases of the carrageenan-induced paw edema test.
wo-way ANOVA/Bonferroni, p-values versus negative control: *p < 0.05, **p < 0.01. the control of the neurogenic (early phase) and inﬂammatory pain (late phase) of
.
the glucocorticoid receptors, which are related to inﬂammatory
response (Augustin et al., 2011). The pharmacological interest by
coumarins is due, particularly, to their bacteriostatic and anti-
tumor activities and their capacity of undoing high protein edemas
(Jain and Joshi, 2011), which may  also contribute for the antiede-
matogenic effect of PMFA. In turn, the presence of condensed
tannins in J. acuminatissima, that are easily extracted by water,
suggests good antioxidant potential for PMFA, as shown in the NO
production assay.
Côrrea and colleagues (2014b) investigated the anti-
inﬂammatory properties of other organic extracts and compounds
isolated from J. acuminatissima, getting good results. They also
isolated four luteolin heterosides of an aqueous extract of J. acumi-
natissima leaves, and conﬁrmed its anti-inﬂammatory activity
(Côrrea et al., 2014a). Interestingly, these researchers used a
model where the inﬂammatory response was  inﬂicted by physical
damage (contusion on hind right paw) and the substances were
administered topically. Here, we  evaluate the capacity of J. acumi-
natissima to inhibit the inﬂammatory response caused by chemical
stimuli (formalin and carrageenan) after oral administration,
and the results have been promising. Thus, the anti-inﬂammatory
potential of J. acuminatissima was  demonstrated by different routes
and stimuli, preliminarily by basing it on its ethnopharmacological
employment.
In order to add more information to the knowledge of the chem-
ical composition of the aqueous extract of J. acuminatissima, we
investigated the presence of twelve substances (friedelin, gallic
acid, 1,8-hydroxiquinone, lupeol, rutin, -stigmasterol, quercetin,
p-cumaric acid, kaempferol, naringenin, scopoletin and umbillifer-
one) in our extract by HPLC–DAD. None of the substances screened
were detected by this method, however, the substances previ-
ously identiﬁed in the aqueous extract support the observed results
(Côrrea et al., 2014a).
With the results of studies with J. acuminatissima until now,
we can conclude that the species is rich in biologically active
compounds and has good anti-inﬂammatory capacity, being able
to signiﬁcantly inhibit inﬂammation caused by different types of
stimuli, especially chemical and physical, without critical effects
after acute exposure to high doses. Thus, these results can con-
tribute to the validation of the main popular use of the species.
As noted in our work, it is interesting to investigate in an upcom-
ing study whether PMFA interferes with the action of PGE2 or other
related mediators involved in the physiology of inﬂammatory pain.Authors’ contributions
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